30
Participants
Start Date
August 31, 2013
Primary Completion Date
November 30, 2013
Study Completion Date
February 28, 2014
Udenafil
Udenafil is administered
Bosentan
Bosentan is administered
Udenafil/Bosentan
Udenafil and Bosentan are administered
Severance Hospital Clinical Trial Center, Seoul
Lead Sponsor
Dong-A ST Co., Ltd.
INDUSTRY
Dong-A Pharmaceutical Co., Ltd.
INDUSTRY